Here are relevant reports on : typhoid-vaccine-market
-
Pharmaceutical Manufacturing Software Market by Offering (AI-Integrated), Type (MES, SCADA, Quality Compliance, EPR, Track & Trace), Application (Biologics, Vaccine), End User (Pharma, Biotech, CDMO), Trend, Growth, Market Share - Global Forecast to 2030
The global Pharmaceutical Manufacturing Software market, valued at US$3.10 billion in 2024, stood at US$3.41 billion in 2025 and is projected to advance at a resilient CAGR of 10.1% from 2025 to 2030, culminating in a forecasted valuation of US$5.52 billion by the end of the period. The development is largely predetermined by the rise in regulatory compliance and the need to use digital and automated manufacturing solutions, the necessity to provide data integrity and traceability, and the increased need to produce pharmaceuticals worldwide.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cryo-electron Microscopy Market by Product & Service (Instruments, Software, Services), Technology (Electron Crystallography, Cryo-ET), Voltage (300 kV), Application (Cancer, Omics, Gene Therapy, Nanotechnology, Vaccine) & Region - Global Forecasts to 2028
The global cryo-electron microscopy market in terms of revenue was estimated to be worth $1.1 billion in 2022 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 11.6% from 2022 to 2028. As of 2021, prominent players in the global market are Thermo Fisher Scientific (US), Danaher (US), JEOL Ltd. (Japan), Intertek Group Plc (UK), and Charles River Laboratories (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Tangential Flow Filtration Market by Product (Single Use Systems, Cassettes, Capsules), Material (PES, PVDF), Technique (Ultrafiltration), Application (Protein, Vaccine, API, Cell Separation), Scale of Operation (R&D), End User - Global Forecast to 2030
The global tangential flow filtration market, valued at US$1.76 billion in 2024, stood at US$1.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.20 billion by the end of the period. Several factors contribute to the growth of the tangential flow filtration market, including the increasing adoption of single-use technologies and the rising demand for scalable & high-throughput purification systems in biologics manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Asia Pacific cell culture Market, valued at US$6.49 billion in 2024, stood at US$6.98 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$12.40 billion by the end of the period. Biopharma companies in the region are expanding the production of monoclonal antibodies, vaccines, biosimilars, and recombinant proteins based on cell culture in the Asia Pacific cell culture market, which is thus growing.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cancer Vaccines Market by Type (Preventive, Therapeutic (Neoantigen)), Technology (Cell-based Vaccine, Recombinant), Indication (Cervical, Prostate), ROA (Intramuscular, Intravenous), End User (Hospitals, Speciality Clinics) - Global Forecast to 2032
The global cancer vaccines market, valued at US$9.70 billion in 2023, stood at US$9.84 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2032, culminating in a forecasted valuation of US$15.00 billion by the end of the period. The cancer vaccines market is growing rapidly, fueled by rising prevalence of cancer, technological advancements in immunotherapy, and increasing adoption of preventive healthcare across the globe.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End user (Pharma & CROs) & Region - Global Forecast to 2030
The global central lab services/clinical trial lab services market, valued at US$5.64 billion in 2024, stood at US$5.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growth of the Asia Pacific central lab services/clinical trial lab services market can be attributed to the increasing prevalence of chronic diseases, such as cancer, kidney diseases, and CVDs.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028
The global cell culture media market, valued at US$5.5 billion in 2022, stood at US$6.2 billion in 2023 and is projected to advance at a resilient CAGR of 16.0% from 2023 to 2028, culminating in a forecasted valuation of US$13.0 billion by the end of the period. Factors such as the growing focus on personalized medicine, increased investment in stem cell research, increasing demand for serum and animal component-free media and increasing demand for monoclonal antibodies and biosimilars are driving the growth of the cell culture media industry.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
EliSpot and FluoroSpot Assay Market by Product (Assay kit (Technique, Utility, Analyte (T Cell and B Cell assay)), Analyzer), Application (Transplants, Infectious Diseases, Vaccine Development, Cancer Research), End User & Region - Global Forecast to 2028
The global EliSpot and FluoroSpot assay market, valued at US$272 million in 2022, stood at US$292 million in 2023 and is projected to advance at a resilient CAGR of 7.6% from 2023 to 2028, culminating in a forecasted valuation of US$421 million by the end of the period. The expansion of this market is majorly due to up surging cases of chronic diseases such as cancer as well as growing Growth in biotechnology and biopharmaceutical industries.
- Published: November 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
